APA (7th ed.) Citation

Lin, Y., Zhang, Z., Zhong, J., Wang, Z., Peng, Y., Lin, Y., . . . Tian, J. Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Lin, Yu-Hao, Zhi-Jun Zhang, Jin-Qing Zhong, Zhi-Yi Wang, Yi-Ting Peng, Yan-Mei Lin, Huo-Ping Zhang, and Jian-Qing Tian. Semaglutide Combined with Empagliflozin Vs. Monotherapy for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes: Study Protocol for a Randomized Clinical Trial. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Lin, Yu-Hao, et al. Semaglutide Combined with Empagliflozin Vs. Monotherapy for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes: Study Protocol for a Randomized Clinical Trial. Public Library of Science (PLoS).